AstraZeneca

News

Calquence approval another win for AstraZeneca in oncology

AstraZeneca has received another boost to its aspirations in oncology with the FDA approval of Calquence, a next generation treatment for mantle cell lymphoma (MCL).

News

AZ licenses rare disease drug to Mereo BioPharma

Mereo Biopharma snaps up drug for AATD.

News

AstraZeneca files Imfinzi for groundbreaking lung cancer use

AZ also unveils promising results from early-stage lung cancer combination

News

China to accept overseas clinical trial data

The Chinese government has announced plans to accept data from clinical trials carried out overseas, in order to speed up approvals.

News

AstraZeneca calls for three year Brexit transition

Pharma at odds with Brexit hard-liners

News

AZ to file COPD combo in China and Japan

AstraZeneca is planning filings of its chronic obstructive pulmonary disease drug Bevespi Aerosphere in China and Japan, based on a new set of positive phase 3 trial results.

Calquence approval another win for AstraZeneca in oncology

AZ licenses rare disease drug to Mereo BioPharma

AstraZeneca files Imfinzi for groundbreaking lung cancer use

China to accept overseas clinical trial data

AstraZeneca calls for three year Brexit transition

AZ to file COPD combo in China and Japan

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

AstraZeneca

Editor's Picks